PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study

PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study

Abstract Background To evaluate the efficacy and safety of pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF) in preventing neutropenia during multiple cycles of chemotherapy in patients with non–small cell lung cancer (NSCLC). Method In a multicenter, prospective, rando...

Full description

Bibliographic Details
Main Authors: Xu‐Sheng Sun, Zhe Wang, Shu‐Hua Ren, He‐Lin Zhang, Li‐Jun Liu, Hong‐Bo Du, Xiao‐Wei Liu, Jun‐Feng Liu
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Thoracic Cancer
Subjects:
multiple cycles of chemotherapy
neutropenia
non–small cell lung cancer
PEG‐rhG‐CSF
primary prophylactic
Online Access:https://doi.org/10.1111/1759-7714.14544

Internet

https://doi.org/10.1111/1759-7714.14544

Similar Items